Multiple Myeloma Today spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on bispecific T-cell engagers (BiTEs) for multiple myeloma, and considerations for selecting between BiTEs and CAR T therapy in the clinic.